Taxation as Prevention and as a Treatment for Obesity: The Case of Sugar-Sweetened Beverages

E-ISSN： 1873-4286|17|12|1218-1222

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.12, 2011-04, pp. : 1218-1222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physical activity and body functionality: implications for obesity prevention and treatment

By Tremblay Angelo Therrien Fanny

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 2, 2006-02 ,pp. : 149-156

NRC Research Press

Access to resources Recommend Favorite

Evaluation of lorcaserin for the treatment of obesity

By Berlie Helen D

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1053-1059

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Approaches for the Treatment of Obesity

By Fernández-López J-A.

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 915-944

Adis International

Access to resources Recommend Favorite

Orlistat in the treatment of obesity

By Ballinger A.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 841-847

Informa Healthcare

Access to resources Recommend Favorite

Orexins and the treatment of obesity

By Smart D. Haynes A.C. Williams G. Arch J.R.S.

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 199-212

Elsevier

Access to resources Recommend Favorite